Lv0
0 积分 2025-04-21 加入
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
5小时前
已完结
JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety
5小时前
已完结
Improvement of Pruritus and Efficacy in the Early Stage of Therapy with Upadacitinib, Abrocitinib, or Dupilumab in Chinese Patients with Moderate-to-Severe Atopic Dermatitis: Prospective, Cohort, Observational Study
17天前
已完结
皖公网安备34019202002308
